Alliance A091104: A phase II trial of MK-2206 in patients (pts) with progressive, recurrent/metastatic adenoid cystic carcinoma.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.6039 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 6039-6039 ◽

Author(s):

Alan Loh Ho ◽

Nathan R. Foster ◽

Jeffrey P. Meyers ◽

Shyamprasad Deraje Vasudeva ◽

Nora Katabi ◽

...

Keyword(s):

Adenoid Cystic Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Download Full-text

919MO ACCURACY a phase II trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) harboring Notch activating mutations (Notchmut)

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1034 ◽

2020 ◽

Vol 31 ◽

pp. S663

Author(s):

R. Ferrarotto ◽

L.J. Wirth ◽

J. Muzaffar ◽

C.P. Rodriguez ◽

B. Xia ◽

...

Keyword(s):

Adenoid Cystic Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Gamma Secretase ◽

Activating Mutations ◽

Adenoid Cystic ◽

Secretase Inhibitor ◽

Gamma Secretase Inhibitor

Download Full-text

Phase II trial of doxorubicin (D) and bortezomib (B) in patients with incurable adenoid cystic carcinoma of the head and neck.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.tps271 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS271-TPS271

Author(s):

A. P. Kotsakis ◽

W. E. Gooding ◽

A. Argiris

Keyword(s):

Adenoid Cystic Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Phase Ii Trial ◽

Download Full-text

Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors

Annals of Oncology ◽

10.1093/annonc/mdv537 ◽

2016 ◽

Vol 27 (2) ◽

pp. 318-323 ◽

Author(s):

S.J. Wong ◽

T. Karrison ◽

D.N. Hayes ◽

M.S. Kies ◽

K.J. Cullen ◽

...

Keyword(s):

Adenoid Cystic Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Download Full-text

Abstract CT165: A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma

10.1158/1538-7445.am2021-ct165 ◽

2021 ◽

Author(s):

Glenn J. Hanna ◽

Anne O'Neill ◽

Jennifer M. Cutler ◽

Michelle Flynn ◽

Tushara Vijaykumar ◽

...

Keyword(s):

Retinoic Acid ◽

Adenoid Cystic Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Adenoid Cystic ◽

Trans Retinoic Acid ◽

All Trans Retinoic Acid

Download Full-text

Local Control following Combination Hypofractionated Radiotherapy and Pembrolizumab in A Phase II Trial of Recurrent or Metastatic Adenoid Cystic Carcinoma Patients

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2019.06.1700 ◽

2019 ◽

Vol 105 (1) ◽

pp. E363

Author(s):

A. Bang ◽

U. Mahmood ◽

Y.H. Chen ◽

R.H. Mak ◽

J. Lorch ◽

...

Keyword(s):

Adenoid Cystic Carcinoma ◽

Phase Ii ◽

Local Control ◽

Phase Ii Trial ◽

Hypofractionated Radiotherapy ◽

Download Full-text

57 Local Control Following Combination Hypofractionated Radiotherapy and Pembrolizumab in a Phase II Trial of Recurrent or Metastatic Adenoid Cystic Carcinoma Patients

Radiotherapy and Oncology ◽

10.1016/s0167-8140(19)33345-6 ◽

2019 ◽

Vol 139 ◽

pp. S26-S27

Author(s):

Andrew Bang ◽

Umair Mahmood ◽

Yu-Hui Chen ◽

Raymond H. Mak ◽

Jochen H. Lorch ◽

...

Keyword(s):

Adenoid Cystic Carcinoma ◽

Phase Ii ◽

Local Control ◽

Phase Ii Trial ◽

Hypofractionated Radiotherapy ◽

Download Full-text

904P ACCURACY: A phase II trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) harboring Notch activating mutations (Notchmut): Results of 6-mg cohort

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1314 ◽

2021 ◽

Vol 32 ◽

pp. S803-S804

Author(s):

A.L. Ho ◽

D.W. Bowles ◽

C. Even ◽

D. Hao ◽

H. Kang ◽

...

Keyword(s):

Adenoid Cystic Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Gamma Secretase ◽

Activating Mutations ◽

Adenoid Cystic ◽

Secretase Inhibitor ◽

Gamma Secretase Inhibitor

Download Full-text

Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck

Head & Neck ◽

10.1002/hed.23577 ◽

2014 ◽

Vol 37 (2) ◽

pp. 182-187 ◽

Author(s):

David J. Thomson ◽

Priyamal Silva ◽

Kim Denton ◽

Suzanne Bonington ◽

Soo K. Mak ◽

...

Keyword(s):

Adenoid Cystic Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Phase Ii Trial ◽

Salivary Adenoid Cystic Carcinoma ◽

Download Full-text

Phase II trial of apatinib in patients with recurrent and/or metastatic adenoid cystic carcinoma of the head and neck: Updated analysis.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.6026 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 6026-6026

Author(s):

Guopei Zhu ◽

Lin Zhang ◽

Rongrong Li ◽

Shengjin Dou ◽

Wenjun Yang ◽

...

Keyword(s):

Adenoid Cystic Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Phase Ii Trial ◽

Download Full-text

A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma

Oral Oncology ◽

10.1016/j.oraloncology.2021.105366 ◽

2021 ◽

Vol 119 ◽

pp. 105366

Author(s):

Glenn J. Hanna ◽

Anne ONeill ◽

Jennifer M. Cutler ◽

Michelle Flynn ◽

Tushara Vijaykumar ◽

...

Keyword(s):

Retinoic Acid ◽

Adenoid Cystic Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Adenoid Cystic ◽

Trans Retinoic Acid ◽

All Trans Retinoic Acid

Download Full-text